FPF
PTX

FNY Partners Fund’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

FNY Partners Fund’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-500
Closed -$1K – 1503
2017
Q1 		$1K Buy
+500
New +$1.57K ﹤0.01% 1380

Other funds holding PTX

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Virtu KCG Holdings
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

FNY Partners Fund's PTX Position: Q2 2017 in Review

FNY Partners Fund sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2017, closing a stake of 500 shares — an estimated $1K sold.

FNY Partners Fund first reported a position in PTX in Q1 2017 and held it in 1 quarter. The position peaked at $1K in Q1 2017. 30 funds tracked by Wall St. Rank hold PTX as of Q2 2017.

  • FNY Partners Fund reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2017 after selling out during the quarter.
  • FNY Partners Fund sold 500 Pernix Therapeutics Holdings, Inc. shares in Q2 2017, an estimated $1K.
  • FNY Partners Fund first reported a position in Pernix Therapeutics Holdings, Inc. in Q1 2017 and held it in 1 quarter.
  • FNY Partners Fund's Pernix Therapeutics Holdings, Inc. position peaked at $1K in Q1 2017.
  • 30 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2017.

Based on FNY Partners Fund's 13F filing for Q2 2017, filed 10 Aug 2017.